Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Seroprevalence and Vaccination in Chinese College Students
NCT01861613Phase 4Completed
- Start
- Sep 2009
- Primary completion
- Nov 2011
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV). Primary endpoint: Anti-HBs immune response in participants negative for HBsAg, anti-HBs and anti-HBc at Month 7. Started Sep 2009; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01861613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01861613.